Background: SARS-CoV-2 is a respiratory virus with neurological complications including
the loss of smell and taste, headache, and confusion that can persist for months or longer …

Since December 2019, the world has been experiencing the COVID-19 pandemic caused
by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and we now face …

The emerging SARS-CoV-2 variants of concern (VOCs) may display enhanced
transmissibility, more severity and/or immune evasion; however, the pathogenesis of these …

Background: The recently emerged variants of the severe acute respiratory coronavirus 2
(SARS-CoV-2) pose a threat to public health. Understanding the pathogenicity of these …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the current
pandemic, resulting in millions of deaths worldwide. Increasingly contagious variants of …

Animal models are used in preclinical trials to test vaccines, antivirals, monoclonal
antibodies, and immunomodulatory drug therapies against SARS-CoV-2. However, these …

The rapid emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has created a global health emergency. While most human disease is mild to moderate …

The continued evolution and emergence of novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) variants have resulted in challenges to vaccine and antibody …

SARS-CoV-2 variants of concern (VOC) B. 1.1. 7 (alpha) and B. 1.351 (beta) show increased
transmissibility and enhanced antibody neutralization resistance. Here we demonstrate in …

Several models were developed to study the pathogenicity of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) as well as the in vivo efficacy of vaccines and …